Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Entera Bio (ENTX) Shares Issued (2019 - 2025)

Entera Bio has reported Shares Issued over the past 6 years, most recently at $71000.0 for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 384.0% year-over-year to $71000.0, compared with a TTM value of $12.4 million through Dec 2025, up 1783.61%, and an annual FY2025 reading of $6.3 million, up 734.98% over the prior year.
  • Shares Issued came in at $71000.0 for Q3 2025, down from $6.2 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $9.9 million in Q1 2021 to a low of -$25000.0 in Q3 2024.
  • Median Shares Issued over the past 4 years was $1.5 million (2021), compared with a mean of $3.5 million.
  • The sharpest move saw Shares Issued soared 14397.06% in 2021, then skyrocketed 384.0% in 2025.
  • Over 4 years, Shares Issued stood at $2.5 million in 2021, then crashed by 100.2% to -$5000.0 in 2023, then surged by 2680.0% to $129000.0 in 2024, then plummeted by 44.96% to $71000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Shares Issued are $71000.0 (Q3 2025), $6.2 million (Q2 2025), and $6.2 million (Q1 2025).